S3 cannabidiol proposal

TGA scheduling delegate proposes pharmacist-only dispensing of low-dose cannabidiol The Therapeutic Goods Administration (TGA) Joint scheduling committee is set to hear a delegate-initiated proposal to allow pharmacist-only supply of low dose cannabidiol products. The move follows the conclusions of a TGA review that concluded S3 dispensing of cannabidiol presents a good safety and tolerability profile